Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Science, medicine and phenylketonuria

C R Scriver1

  • 1Department of Pediatrics, McGill University, Montreal, Canada.

Acta Paediatrica (Oslo, Norway : 1992). Supplement
|December 1, 1994
PubMed
Summary

Phenylketonuria (PKU) research uncovered its genetic causes and metabolic pathways. Early diagnosis and dietary phenylalanine management significantly improved PKU

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

A Commentary on Multiple Screening for Aminoacidopathies in the Newborn Infant.

Canadian Medical Association journal·2010
Same author

Significance of the fellowship examination for canadian medical scientists.

Canadian Medical Association journal·2010
Same author

What we know that could influence future treatment of phenylketonuria.

Journal of inherited metabolic disease·2008
Same author

The birth prevalence of PKU in populations of European, South Asian and sub-Saharan African ancestry living in South East England.

Annals of human genetics·2008
Same author

Recommendations for locus-specific databases and their curation.

Human mutation·2007
Same author

CpG methylation accounts for a recurrent mutation (c.1222C>T) in the human PAH gene.

Human mutation·2006

Area of Science:

  • Biochemistry
  • Genetics
  • Metabolic Disorders

Background:

  • Phenylketonuria (PKU) is a genetic disorder with significant neurological implications.
  • Understanding PKU's genetic and metabolic basis is crucial for effective management.

Purpose of the Study:

  • To detail the scientific discovery of PKU's causes and phenotypes.
  • To highlight the impact of newborn screening and early treatment on PKU outcomes.
  • To explore the genetic heterogeneity and population distribution of PKU mutations.

Main Methods:

  • Investigated ultimate (allelic heterogeneity at PAH locus) and proximate (dietary phenylalanine) causes.
  • Analyzed proximal (phenylalanine hydroxylase deficiency) and distal (cognitive impairment) phenotypes.
  • Utilized population studies to identify genetic heterogeneity in hyperphenylalaninemia.

Main Results:

  • Discovered allelic heterogeneity at the PAH locus and identified over 170 mutant PAH alleles by April 1994.
  • Established the link between phenylalanine hydroxylase deficiency and metabolic/cognitive phenotypes.
  • Revealed genetic heterogeneity in hyperphenylalaninemia involving four additional loci.

Conclusions:

  • Scientific advancements have led to the discovery of PKU's complex genetic and metabolic underpinnings.
  • Newborn screening and early dietary intervention have greatly ameliorated PKU's neurological impact.
  • Population genetics studies reveal diverse mutation spectra and geographic distributions, influenced by factors like founder effect and selection.

Related Experiment Videos